Our Mission...
is to improve the quality of health service delivery and reduce the burden of disease and disability in the United States and elsewhere by carrying out broadly based research and education activities involving the translation of innovative medical research into practice

PUBLICATIONS

2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004

 

2013

 

Ashwood ER, Palomaki GE: A new era in noninvasive prenatal testing. N Engl J Med, 369:2164, 2013.

Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N: Comparative effectiveness review: Prostate cancer antigen 3 (PCA3) testing for the diagnosis and management of prostate cancer. J Urol, 190:389-398, 2013.

Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE: The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn, 33:667-674, 2013.

Craig WY, Palomaki GE, Neveux LM, Haddow JE: Matneral body mass index during pregnancy and offspring neurocognitive development. Obstet Med, 6:20-25, 2013.

Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D'Alton ME for the First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium: Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy. Thyroid, 23:255-260, 2013.

Haddow JE: Maternal thyroxine and fetal brain development: The latest chapter, a look back, and considerations for the future. J Clin Endocrinol Metab, 98:1388-1390, 2013.

Jensen TJ, Zwiefelhofer T, Tim RC, Dzakula Z, Kim SK, Mazloom AR, Zhu Z, Tynan J, Lu T, McLennan G, Palomaki GE, Canick JA, Oeth P, Deciu C, van den Boom D, Ehrich M: High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLoS One, 8:e57381, 2013.

Mazloom A, Dzakula Z, Wang H, Oeth P, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard A, Maeder M, McLennan G, Meschino W, Palomaki G, Canick J, Deciu C: Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn, 33:591-597, 2013.

Palomaki GE, Melillo S, Marrone M, Douglas MP: Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review, Genet Med, 15:600-611, 2013.

Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE: Screening for Down syndrome in the United States: Results of surveys in 2011 and 2012. Arch Pathol Lab Med, 137:921-926, 2013.

Recommendations from the EGAPP Working Group: Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Genet Med, 15:517-527, 2013.

Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, Tunis SR, Djulbegovic B, Marrone M, Line JS, Berg AO, Calonge N, on behalf of the EGAPP Working Group: Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP method update. Genet Med, 15:14-24, 2013.

Wald NJ, Lambert-Messerlian G, Palomaki GE: Dr. Jacob (Jack) Canick -- an appreciation. Prenat Diagn, 33:813-814, 2013.